Korea Stocks, page 30 of 36 — 24 articles published 2026-07-06 ~ 2026-07-09.
Haesung DS (KOSPI: 195870) 2026 stock analysis for global investors: a Roll-to-Roll automotive semiconductor leadframe moat, memory- and server-oriented package (BGA) substrate growth, copper and raw-material cost pass-through, KRW/USD currency risk, the semiconductor cycle, customer-concentration exposure, and dividend appeal, all framed qualitatively.
Daeduck Electronics (KOSPI 353200) stock outlook for 2026, analyzing its pivot from low-margin PCBs to high-value FC-BGA semiconductor package substrates, AI, server and telecom demand, Samsung and other customer exposure, the memory-chip cycle, heavy capex, and competition from Japanese and Greater China rivals, plus KRW currency risk for global investors.
CLIO (KOSDAQ 237880) 2026 stock analysis: Peripera, Goodal, and CLIO brand portfolio, Olive Young H&B channel plus online and global (Japan, US Amazon) expansion, indie-brand competition, cost and marketing structure, and channel-dependence, China-exposure, and trend-sensitivity risks.
Lotte Fine Chemical (KOSPI: 004000) 2026 stock analysis: high-margin food-and-pharma cellulose derivatives (HECELLOSE, AnyCoat) versus commodity chlor-alkali and ammonia cycles, UREX diesel-exhaust fluid, green hydrogen and carbon-free ammonia optionality, net-cash balance sheet, dividend appeal, and Lotte Group risk for foreign investors.
Maeil Dairies (267980) 2026 stock analysis: how a Korean dairy leader is pivoting away from a shrinking white-milk and infant-formula base toward Selex adult nutrition, plant-based Almond Breeze, protein, exports, raw-milk pricing margins, and the Maeil Holdings structure.
Paradise Co (034230, KOSDAQ) 2026 stock analysis: foreigner-only casino model, drop and hold-rate mechanics, Chinese and Japanese VIP recovery, inbound tourism and yen-weakness effects, Paradise City integrated-resort synergy with Sega Sammy, and the macro risks that drive this cyclical name.
Youngone Corporation (KRX: 111770) 2026 stock analysis: the world-scale outdoor OEM/ODM engine behind The North Face, Patagonia, and lululemon, Bangladesh wage and stability risk, the Scott Sports bicycle slump, dollar-revenue FX tailwind, and a fortress net-cash balance sheet — analyzed qualitatively.
Binggrae (KRX: 005180) 2026 stock analysis: ice cream duopoly after the Haitai acquisition, input-cost and seasonality dynamics, Melona-led K-food export growth, low-birthrate domestic risk, and dividend appeal — a qualitative deep dive for global investors.
Daehan Petrochemical (KRX: 006650, DYP) 2026 stock analysis: naphtha cracking (NCC) economics, PE and PP spread compression from Chinese oversupply, ultra-high-molecular-weight PE battery-separator materials, a deep net-cash balance sheet, asset-value support, and cyclical recovery leverage — framed for US and international investors.
Ildong Pharmaceutical (KRX: 249420) 2026 stock analysis: Aronamin and GQ-Lab OTC brand cash cows versus R&D losses at spun-off drug-discovery unit Yuhno-via, GLP-1 diabetes and obesity pipeline, licensing-out upside, Ildong Holdings structure, drug-pricing regulation risk, and balance-sheet improvement.
JW Pharmaceutical (KOSPI 001060) 2026 stock analysis: the high-barrier basic IV-fluid business, cash-cow prescription drugs like Livalo, a Wnt-targeting oncology pipeline, JW Holdings governance, drug-pricing regulation risk, and dividends — for investors accessing KOSPI directly.
Nexen Tire (002350) 2026 stock analysis: natural and synthetic rubber cost spreads, ocean-freight exposure, European and North American OE expansion, EV-specific tires, Czech plant depreciation and debt, mid-market positioning versus Michelin and Bridgestone, and dividend and tax considerations for global investors.
DoubleU Games (KRX 192080) Stock Outlook 2026 covering the social casino business model (DoubleU Casino and DoubleDown), in-app-purchase revenue engine, the NASDAQ-listed DoubleDown Interactive (DDI) subsidiary stake, high margins and low valuation versus market growth slowdown, regulation and platform fees, iGaming expansion, MAU/ARPPU metrics and what global investors should watch.
Seegene (KRX 096530) Stock Outlook 2026 covering the post-COVID normalization (negative base effect), syndromic multiplex PCR diagnostics, lab-automation platform, the instrument-plus-reagent razor-and-blade model, overseas localization and technology-transfer strategy, growth doubts, peer comparison and what global investors should watch.
Medytox (KRX 086900) Stock Outlook 2026 covering the Meditoxin, Coretox and Newlux botulinum toxin lineup, hyaluronic acid fillers, China approval and US expansion, the Daewoong strain lawsuit and regulatory risk, a Korean toxin peer comparison, and what global investors should watch.
FILA Holdings (KRX 081660) Stock Outlook 2026 covering the global FILA sports-and-casual brand across Korea, the US and China, the Acushnet (Titleist, FootJoy) golf equity stake and its equity-method earnings, brand rebranding and royalty revenue, consumer-cyclical and currency risk, a consumer-brand peer comparison and what global investors should watch.
Tokai Carbon Korea (KRX 064760, TCK) Stock Outlook 2026 covering high-purity consumable parts for semiconductor etch, its world-leading Solid SiC Ring moat, supply to Samsung and SK hynix, high operating margins, the Tokai Carbon parent relationship, sensitivity to fab utilization and capex cycles, competitive-entry and customer-concentration risks, materials-peer comparison and what global investors should watch.
KEPCO Engineering & Construction (KRX 052690) Stock Outlook 2026 covering its near-monopoly in nuclear plant design engineering, new reactors and Czech export orders, the SMR opportunity, an order-based revenue model, policy and order-flow risk, practical scenarios and a nuclear value-chain comparison for global investors.
Handsome (KRX 020000) Stock Outlook 2026 covering the TIME, MINE, SYSTEM and SJSJ premium brand portfolio, thehandsome.com online and China overseas expansion, domestic consumption cyclicality, margin and inventory discipline, dividend appeal, peer comparison with Shinsegae International, F&F and Fila, and what global investors should watch.
Douzone Bizon (KRX 012510) Stock Outlook 2026 covering the shift from on-premise ERP to cloud subscription revenue, the WEHAGO business platform and e-tax invoicing, receivables-factoring fintech expansion, growth-stock valuation, SME IT demand, Korean software peer comparison and what global investors should watch.
Hyosung Corporation (KRX 004800) Stock Outlook 2026 covering the holding-company structure and stakes in Hyosung TNC, Hyosung Heavy Industries, Hyosung Advanced Materials and Hyosung Chemical, the dividend and brand-royalty revenue model, the NAV discount and cyclical subsidiary risk, governance and succession issues, a peer comparison versus other holdcos and what global investors should watch.
Daesang Corporation (KRX 001680) Stock Outlook 2026 covering the Chung Jung One, Jongga and Miwon consumer food brands, the starch-sugar, amino-acid and lysine fermentation B2B materials business, grain-cost and FX sensitivity, Indonesia and Vietnam expansion, bio-fermentation growth, dividends, peer comparison and what global investors should watch.
Kolon Industries (120110) 2026 stock analysis: tire cord and aramid super-fiber (ballistic, 5G, EV electrification), hydrogen fuel-cell membrane materials as a long-term option, petroleum resin and film cyclicality, the Kolon Mall fashion arm, holding-company governance, and how this Korea-listed materials conglomerate blends structural growth with cyclical risk.
Dongjin Semichem (KRX 005290) Stock Outlook 2026: a full breakdown of its photoresist, thinner and stripper semiconductor and display materials, the EUV photoresist localization story, Samsung and SK Hynix supply, CNT conductive-additive battery materials, the Korean materials-policy tailwind, risks, peer comparison, and what global investors should watch.